...
cing-img

Cingulate Inc, Common Stock

CING

NAQ

$4.76

+$0.66

(16.1%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$13.17M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
265.70K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
-0.91
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.8 L
$152.4 H
$4.76

About Cingulate Inc, Common Stock

Cingulate Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. The company's stimulant medications are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, as well as CTx-1302 (dextroamphetamine), which is in investigational new drug application development for the treatment of attention deficit/hyperactivity disorder intended for children, adolescents, and adults. It also focuses on developing CTx-2103 that is in a formulation stage for the treatment of anxiety. The company was founded in 2012 and is headquartered in Kansas City, Kansas. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameCINGSectorS&P500
1-Week Return18.11%-0.94%-2.6%
1-Month Return1.28%-5.08%-1.08%
3-Month Return-7.03%-10.62%3.45%
6-Month Return-34.65%-6.18%8.57%
1-Year Return-79.97%1.98%24.3%
3-Year Return-99.22%-0.93%25.58%
5-Year Return-99.55%33.84%84.07%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue178.91K842.35K808.44K621.99K582.92K[{"date":"2019-12-31","value":21.24,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":95.97,"profit":true},{"date":"2022-12-31","value":73.84,"profit":true},{"date":"2023-12-31","value":69.2,"profit":true}]
Gross Profit(178.91K)(842.35K)(808.44K)(621.99K)(582.92K)[{"date":"2019-12-31","value":-17891200,"profit":false},{"date":"2020-12-31","value":-84235300,"profit":false},{"date":"2021-12-31","value":-80844100,"profit":false},{"date":"2022-12-31","value":-62199300,"profit":false},{"date":"2023-12-31","value":-58291800,"profit":false}]
Gross Margin-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Operating Expenses11.65M7.08M20.68M17.50M22.76M[{"date":"2019-12-31","value":51.17,"profit":true},{"date":"2020-12-31","value":31.13,"profit":true},{"date":"2021-12-31","value":90.86,"profit":true},{"date":"2022-12-31","value":76.9,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(11.65M)(7.08M)(20.68M)(17.50M)(22.76M)[{"date":"2019-12-31","value":-1164726000,"profit":false},{"date":"2020-12-31","value":-708336300,"profit":false},{"date":"2021-12-31","value":-2067939800,"profit":false},{"date":"2022-12-31","value":-1750171800,"profit":false},{"date":"2023-12-31","value":-2275919000,"profit":false}]
Total Non-Operating Income/Expense202.36K(200.50K)(61.19K)(349.03K)(1.54M)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-99.08,"profit":false},{"date":"2021-12-31","value":-30.24,"profit":false},{"date":"2022-12-31","value":-172.48,"profit":false},{"date":"2023-12-31","value":-762.99,"profit":false}]
Pre-Tax Income(11.55M)(7.18M)(20.71M)(17.68M)(23.53M)[{"date":"2019-12-31","value":-1154586400,"profit":false},{"date":"2020-12-31","value":-718452900,"profit":false},{"date":"2021-12-31","value":-2070999100,"profit":false},{"date":"2022-12-31","value":-1767623200,"profit":false},{"date":"2023-12-31","value":-2353494700,"profit":false}]
Income Taxes(100.53K)99.34K30.50K174.00K2.00[{"date":"2019-12-31","value":-57.77,"profit":false},{"date":"2020-12-31","value":57.09,"profit":true},{"date":"2021-12-31","value":17.53,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes(11.45M)(7.28M)(20.74M)(17.85M)(23.53M)[{"date":"2019-12-31","value":-1144533600,"profit":false},{"date":"2020-12-31","value":-728386700,"profit":false},{"date":"2021-12-31","value":-2074049300,"profit":false},{"date":"2022-12-31","value":-1785023200,"profit":false},{"date":"2023-12-31","value":-2353494900,"profit":false}]
Income From Continuous Operations(11.55M)(7.18M)(20.71M)(17.68M)(21.21M)[{"date":"2019-12-31","value":-1154629800,"profit":false},{"date":"2020-12-31","value":-718361500,"profit":false},{"date":"2021-12-31","value":-2070999100,"profit":false},{"date":"2022-12-31","value":-1767623200,"profit":false},{"date":"2023-12-31","value":-2120527700,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(11.45M)(7.28M)(20.74M)(17.85M)(23.53M)[{"date":"2019-12-31","value":-1144533600,"profit":false},{"date":"2020-12-31","value":-728386700,"profit":false},{"date":"2021-12-31","value":-2074049300,"profit":false},{"date":"2022-12-31","value":-1785023200,"profit":false},{"date":"2023-12-31","value":-2353494700,"profit":false}]
EPS (Diluted)--(1.84)(1.57)(8.88)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-184,"profit":false},{"date":"2022-12-31","value":-157,"profit":false},{"date":"2023-12-31","value":-888,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

CING
Cash Ratio 6.51
Current Ratio 7353.85

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

CING
ROA (LTM) -104.33%
ROE (LTM) -273.82%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

CING
Debt Ratio Lower is generally better. Negative is bad. 0.11
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.89

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

CING
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 1.11
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Cingulate Inc share price today?

Cingulate Inc (CING) share price today is $4.76

Can Indians buy Cingulate Inc shares?

Yes, Indians can buy shares of Cingulate Inc (CING) on Vested. To buy Cingulate Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CING stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Cingulate Inc be purchased?

Yes, you can purchase fractional shares of Cingulate Inc (CING) via the Vested app. You can start investing in Cingulate Inc (CING) with a minimum investment of $1.

How to invest in Cingulate Inc shares from India?

You can invest in shares of Cingulate Inc (CING) via Vested in three simple steps:

  • Click on Sign Up or Invest in CING stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Cingulate Inc shares
What is Cingulate Inc 52-week high and low stock price?

The 52-week high price of Cingulate Inc (CING) is $152.4. The 52-week low price of Cingulate Inc (CING) is $1.8.

What is Cingulate Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Cingulate Inc (CING) is

What is Cingulate Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Cingulate Inc (CING) is 1.11

What is Cingulate Inc dividend yield?

The dividend yield of Cingulate Inc (CING) is 0.00%

What is the Market Cap of Cingulate Inc?

The market capitalization of Cingulate Inc (CING) is $13.17M

What is Cingulate Inc’s stock symbol?

The stock symbol (or ticker) of Cingulate Inc is CING

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top